Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2017 Filed Mar 16, 2017 21:11 UTC |
Elias Marguerite MEVP, Gen Counsel and Secy
|
GrantPerformance Options (Right to Buy) · Derivative | 29,840 | $0.00 Strike: $11.96 | $0.00 |
DisclosureSEC source: 0001209191-17-021135 · doc4.xml · derivative · entry 3 Elias Marguerite M · CIK 0001297509 · EVP, Gen Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,840 Underlying: Common Stock · 29,840 shares Expires 2027-03-14 F3 · derivative.exercise_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited. F3 · derivative.expiration_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:11 UTC |
Elias Marguerite MEVP, Gen Counsel and Secy
|
GrantOptions (Right to Buy) · Derivative | 58,340 | $0.00 Strike: $11.96 | $0.00 |
DisclosureSEC source: 0001209191-17-021135 · doc4.xml · derivative · entry 2 Elias Marguerite M · CIK 0001297509 · EVP, Gen Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,340 Underlying: Common Stock · 58,340 shares Expires 2027-03-14 F2 · derivative.exercise_date: These options were granted on March 14, 2017 and are scheduled to vest and become exercisable in four equal annual installments on the first four anniversaries of the grant date, subject to continued employment with the Company. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:11 UTC |
Elias Marguerite MEVP, Gen Counsel and Secy
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-021135 · doc4.xml · nonDerivative · entry 1 Elias Marguerite M · CIK 0001297509 · EVP, Gen Counsel and Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,672 F1 · security: Includes restricted shares. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:10 UTC |
COBIN JONATHAN BEVP, Chief Commercial Officer
|
GrantPerformance Restricted Stock Units · Derivative | 3,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-021134 · doc4.xml · derivative · entry 4 COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,840 Underlying: Common Stock · 3,840 shares Expires not disclosed F4 · derivative.exercise_price: Each performance restricted stock unit represents the contingent right to receive one share of the Company's common stock or its equivalent value in cash. F5 · derivative.exercise_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited. F5 · derivative.expiration_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:10 UTC |
COBIN JONATHAN BEVP, Chief Commercial Officer
|
GrantPerformance Options (Right to Buy) · Derivative | 29,840 | $0.00 Strike: $11.96 | $0.00 |
DisclosureSEC source: 0001209191-17-021134 · doc4.xml · derivative · entry 3 COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,840 Underlying: Common Stock · 29,840 shares Expires 2027-03-14 F3 · derivative.exercise_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited. F3 · derivative.expiration_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:10 UTC |
COBIN JONATHAN BEVP, Chief Commercial Officer
|
GrantOptions (Right to Buy) · Derivative | 58,340 | $0.00 Strike: $11.96 | $0.00 |
DisclosureSEC source: 0001209191-17-021134 · doc4.xml · derivative · entry 2 COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,340 Underlying: Common Stock · 58,340 shares Expires 2027-03-14 F2 · derivative.exercise_date: These options were granted on March 14, 2017 and are scheduled to vest and become exercisable in four equal annual installments on the first four anniversaries of the grant date, subject to continued employment with the Company. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:10 UTC |
COBIN JONATHAN BEVP, Chief Commercial Officer
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-021134 · doc4.xml · nonDerivative · entry 1 COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,653 F1 · security: Includes restricted shares. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:09 UTC |
CHARI ANAND KEVP, Engineering and CTO
|
GrantPerformance Restricted Stock Units · Derivative | 3,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-021132 · doc4.xml · derivative · entry 4 CHARI ANAND K · CIK 0001579594 · EVP, Engineering and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,840 Underlying: Common Stock · 3,840 shares Expires not disclosed F4 · derivative.exercise_price: Each performance restricted stock unit represents the contingent right to receive one share of the Company's common stock or its equivalent value in cash. F5 · derivative.exercise_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited. F5 · derivative.expiration_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:09 UTC |
CHARI ANAND KEVP, Engineering and CTO
|
GrantPerformance Options (Right to Buy) · Derivative | 29,840 | $0.00 Strike: $11.96 | $0.00 |
DisclosureSEC source: 0001209191-17-021132 · doc4.xml · derivative · entry 3 CHARI ANAND K · CIK 0001579594 · EVP, Engineering and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,840 Underlying: Common Stock · 29,840 shares Expires 2027-03-14 F3 · derivative.exercise_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited. F3 · derivative.expiration_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:09 UTC |
CHARI ANAND KEVP, Engineering and CTO
|
GrantOptions (Right to Buy) · Derivative | 58,340 | $0.00 Strike: $11.96 | $0.00 |
DisclosureSEC source: 0001209191-17-021132 · doc4.xml · derivative · entry 2 CHARI ANAND K · CIK 0001579594 · EVP, Engineering and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,340 Underlying: Common Stock · 58,340 shares Expires 2027-03-14 F2 · derivative.exercise_date: These options were granted on March 14, 2017 and are scheduled to vest and become exercisable in four equal annual installments on the first four anniversaries of the grant date, subject to continued employment with the Company. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:09 UTC |
CHARI ANAND KEVP, Engineering and CTO
|
GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-021132 · doc4.xml · nonDerivative · entry 1 CHARI ANAND K · CIK 0001579594 · EVP, Engineering and CTO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,087 F1 · security: Includes restricted shares. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:08 UTC |
Bayer Michael P.SVP, Controller & CAO
|
GrantPerformance Restricted Stock Units · Derivative | 930 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-021127 · doc4.xml · derivative · entry 4 Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 930 Underlying: Common Stock · 930 shares Expires not disclosed F1 · derivative.exercise_price: Each performance restricted stock unit represents the contingent right to receive one share of the Company's common stock or its equivalent value in cash. F5 · derivative.exercise_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited. F5 · derivative.expiration_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:08 UTC |
Bayer Michael P.SVP, Controller & CAO
|
GrantPerformance Options (Right to Buy) · Derivative | 7,710 | $0.00 Strike: $11.96 | $0.00 |
DisclosureSEC source: 0001209191-17-021127 · doc4.xml · derivative · entry 3 Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,710 Underlying: Common Stock · 7,710 shares Expires 2027-03-14 F4 · derivative.exercise_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited. F4 · derivative.expiration_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:08 UTC |
Bayer Michael P.SVP, Controller & CAO
|
GrantOptions (Right to Buy) · Derivative | 23,000 | $0.00 Strike: $11.96 | $0.00 |
DisclosureSEC source: 0001209191-17-021127 · doc4.xml · derivative · entry 2 Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,000 Underlying: Common Stock · 23,000 shares Expires 2027-03-14 F3 · derivative.exercise_date: These options were granted on March 14, 2017 and are scheduled to vest and become exercisable in four equal annual installments on the first four anniversaries of the grant date, subject to continued employment with the Company. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 21:08 UTC |
Bayer Michael P.SVP, Controller & CAO
|
GrantRestricted Stock Units · Derivative | 2,910 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-021127 · doc4.xml · derivative · entry 1 Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,110 Underlying: Common Stock · 2,910 shares Expires not disclosed F1 · derivative.exercise_price: Each performance restricted stock unit represents the contingent right to receive one share of the Company's common stock or its equivalent value in cash. F2 · derivative.exercise_date: These restricted stock units vest in four equal installments on the first four anniversaries of March 14, 2017, subject to continued employment with the Company. F2 · derivative.expiration_date: These restricted stock units vest in four equal installments on the first four anniversaries of March 14, 2017, subject to continued employment with the Company. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 22:37 UTC |
CRANDALL ROBERT LDirector
|
Purchase3.75% Senior Convertible Notes due 2020 · Derivative | Not disclosed | $283,336.00 Strike: $23.85 | $355,000.00 |
DisclosureSEC source: 0001209191-17-017828 · doc4.xml · derivative · entry 2 CRANDALL ROBERT L · CIK 0001206595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,355,000 Underlying: Common Stock · 14,885 shares Expires 2020-03-01 F3 · price: Represents the aggregate purchase price for the 3.75% senior convertible notes due 2020. F1 · derivative.exercise_date: The 3.75% senior convertible notes due 2020 become convertible on December 1, 2019 or earlier upon certain events. F2 · derivative.underlying_shares: The 3.75% senior convertible notes due 2020 are convertible into common stock at a conversion price equal to $23.85 per share of the issuer's common stock, subject to adjustment in certain events. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 22:37 UTC |
CRANDALL ROBERT LDirector
|
Purchase3.75% Senior Convertible Notes due 2020 · Derivative | Not disclosed | $811,880.00 Strike: $23.85 | $1,000,000.00 |
DisclosureSEC source: 0001209191-17-017828 · doc4.xml · derivative · entry 1 CRANDALL ROBERT L · CIK 0001206595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 41,929 shares Expires 2020-03-01 F3 · price: Represents the aggregate purchase price for the 3.75% senior convertible notes due 2020. F1 · derivative.exercise_date: The 3.75% senior convertible notes due 2020 become convertible on December 1, 2019 or earlier upon certain events. F2 · derivative.underlying_shares: The 3.75% senior convertible notes due 2020 are convertible into common stock at a conversion price equal to $23.85 per share of the issuer's common stock, subject to adjustment in certain events. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 15:31 UTC |
Jackson KarenSVP, Human Resources
|
Tax withholdingCommon Stock | 379 | $10.49 | $3,975.71 |
DisclosureSEC source: 0001209191-17-015615 · doc4.xml · nonDerivative · entry 1 Jackson Karen · CIK 0001634791 · SVP, Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,093 F1 · security: Includes restricted shares. F2 · balance_after: Includes 2,947 shares acquired under Gogo Inc.'s employee stock purchase plan in transactions that were exempt under Rule 16b-3(c) Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:07 UTC |
Thorndale Farm LLC10% owner
THORNE OAKLEIGHDirector · 10% owner
|
OtherCommon Stock | 433,136 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-005226 · doc4.xml · nonDerivative · entry 1 Thorndale Farm LLC · CIK 0001455402 · 10% owner THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 20,936 F1 · kind: The reported disposition was effected solely in connection with the long-term estate planning of Mr. Thorne and his family. This transfer was not effected in the open market. F2 · ownership.direct: Reflects shares held by the Bertha P. Thorne Trust Under Will dated 12/23/1970 FBO Oakleigh B. Thorne. Mr. Thorne, as a co-trustee of the foregoing trust, may be deemed to have beneficial ownership of the shares held by the trust. Mr. Thorne disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 or for any other purpose. F3 · ownership.direct: Certain of the entities for which shares are reported on this report and certain other entities that hold the issuer's shares have entered into a service agreement with Thorndale Farm, L.L.C., of which Mr. Thorne is the Chief Executive Officer. As such, Thorndale Farm, L.L.C. and Mr. Thorne may be deemed to have beneficial ownership of the shares held by such entities. Thorndale Farm, L.L.C. and Mr. Thorne disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that either Thorndale Farm, L.L.C. or Mr. Thorne is a beneficial owner of such shares for purposes of Section 16 or for any other purpose. Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 21:15 UTC |
Thorndale Farm LLC10% owner
THORNE OAKLEIGHDirector · 10% owner
|
OtherCommon Stock | 90,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-001990 · doc4.xml · nonDerivative · entry 2 Thorndale Farm LLC · CIK 0001455402 · 10% owner THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 1,037,306 F4 · kind: The reported disposition was effected solely in connection with the long-term estate planning of Mr. Thorne and his family. No shares were purchased or sold in connection with the disposition, nor was the transfer effected in the open market. F2 · ownership.direct: Reflects shares held by the 2005 Restatement of the Oakleigh Thorne Trust dated June 23, 1997. Mr. Thorne, as trustee of the foregoing trust, may be deemed to have beneficial ownership of the shares held by the trust. Mr. Thorne disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 or for any other purpose. F3 · ownership.direct: Certain of the entities for which shares are reported on this report and certain other entities that hold the issuer's shares have entered into a service agreement with Thorndale Farm, L.L.C., of which Mr. Thorne is the Chief Executive Officer. As such, Thorndale Farm, L.L.C. and Mr. Thorne may be deemed to have beneficial ownership of the shares held by such entities. Thorndale Farm, L.L.C. and Mr. Thorne disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that either Thorndale Farm, L.L.C. or Mr. Thorne is a beneficial owner of such shares for purposes of Section 16 or for any other purpose. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 14:27 UTC |
MUNDHEIM ROBERT HDirector
|
GrantOptions (Right to Buy) · Derivative | 4,517 | $0.00 Strike: $9.22 | $0.00 |
DisclosureSEC source: 0001209191-17-000708 · doc4.xml · derivative · entry 2 MUNDHEIM ROBERT H · CIK 0001039520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,517 Underlying: Common Stock · 4,517 shares Expires 2026-12-30 Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 14:27 UTC |
MUNDHEIM ROBERT HDirector
|
GrantDeferred Share Units · Derivative | 3,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000708 · doc4.xml · derivative · entry 1 MUNDHEIM ROBERT H · CIK 0001039520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,384 Underlying: Common Stock · 3,660 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 14:26 UTC |
LEMAY RONALD TDirector
|
GrantOptions (Right to Buy) · Derivative | 6,130 | $0.00 Strike: $9.22 | $0.00 |
DisclosureSEC source: 0001209191-17-000706 · doc4.xml · derivative · entry 2 LEMAY RONALD T · CIK 0001104293 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,130 Underlying: Common Stock · 6,130 shares Expires 2026-12-30 Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 14:26 UTC |
LEMAY RONALD TDirector
|
GrantDeferred Share Units · Derivative | 2,575 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000706 · doc4.xml · derivative · entry 1 LEMAY RONALD T · CIK 0001104293 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,083 Underlying: Common Stock · 2,575 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:28 UTC |
THORNE OAKLEIGHDirector · 10% owner
|
GrantOptions (Right to Buy) · Derivative | 4,517 | $0.00 Strike: $9.22 | $0.00 |
DisclosureSEC source: 0001209191-17-000710 · doc4.xml · derivative · entry 2 THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,517 Underlying: Common Stock · 4,517 shares Expires 2026-12-30 Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:28 UTC |
THORNE OAKLEIGHDirector · 10% owner
|
GrantDeferred Share Units · Derivative | 3,524 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000710 · doc4.xml · derivative · entry 1 THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,613 Underlying: Common Stock · 3,524 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:27 UTC |
Payne Christopher DDirector
|
GrantOptions (Right to Buy) · Derivative | 4,517 | $0.00 Strike: $9.22 | $0.00 |
DisclosureSEC source: 0001209191-17-000709 · doc4.xml · derivative · entry 2 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,517 Underlying: Common Stock · 4,517 shares Expires 2026-12-30 Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:27 UTC |
Payne Christopher DDirector
|
GrantDeferred Share Units · Derivative | 1,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000709 · doc4.xml · derivative · entry 1 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,076 Underlying: Common Stock · 1,898 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:30 UTC |
WILLIAMS HARRIS NDirector
|
GrantOptions (Right to Buy) · Derivative | 4,517 | $0.00 Strike: $9.22 | $0.00 |
DisclosureSEC source: 0001209191-17-000714 · doc4.xml · derivative · entry 2 WILLIAMS HARRIS N · CIK 0001579625 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,517 Underlying: Common Stock · 4,517 shares Expires 2026-12-30 Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:30 UTC |
WILLIAMS HARRIS NDirector
|
GrantDeferred Share Units · Derivative | 1,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000714 · doc4.xml · derivative · entry 1 WILLIAMS HARRIS N · CIK 0001579625 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,274 Underlying: Common Stock · 1,898 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:29 UTC |
TOWNSEND CHARLES CDirector
|
GrantOptions (Right to Buy) · Derivative | 4,517 | $0.00 Strike: $9.22 | $0.00 |
DisclosureSEC source: 0001209191-17-000712 · doc4.xml · derivative · entry 2 TOWNSEND CHARLES C · CIK 0001579494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,517 Underlying: Common Stock · 4,517 shares Expires 2026-12-30 Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:29 UTC |
TOWNSEND CHARLES CDirector
|
GrantDeferred Share Units · Derivative | 3,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000712 · doc4.xml · derivative · entry 1 TOWNSEND CHARLES C · CIK 0001579494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,145 Underlying: Common Stock · 3,253 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:26 UTC |
MAYES MICHELE COLEMANDirector
|
GrantOptions (Right to Buy) · Derivative | 4,517 | $0.00 Strike: $9.22 | $0.00 |
DisclosureSEC source: 0001209191-17-000707 · doc4.xml · derivative · entry 2 MAYES MICHELE COLEMAN · CIK 0001224609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,517 Underlying: Common Stock · 4,517 shares Expires 2026-12-30 Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:26 UTC |
MAYES MICHELE COLEMANDirector
|
GrantDeferred Share Units · Derivative | 3,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000707 · doc4.xml · derivative · entry 1 MAYES MICHELE COLEMAN · CIK 0001224609 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,764 Underlying: Common Stock · 3,253 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:24 UTC |
CRANDALL ROBERT LDirector
|
GrantOptions (Right to Buy) · Derivative | 4,517 | $0.00 Strike: $9.22 | $0.00 |
DisclosureSEC source: 0001209191-17-000703 · doc4.xml · derivative · entry 2 CRANDALL ROBERT L · CIK 0001206595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,517 Underlying: Common Stock · 4,517 shares Expires 2026-12-30 Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:24 UTC |
CRANDALL ROBERT LDirector
|
GrantDeferred Share Units · Derivative | 3,253 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000703 · doc4.xml · derivative · entry 1 CRANDALL ROBERT L · CIK 0001206595 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,889 Underlying: Common Stock · 3,253 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:25 UTC |
JONES HUGH WDirector
|
GrantOptions (Right to Buy) · Derivative | 4,517 | $0.00 Strike: $9.22 | $0.00 |
DisclosureSEC source: 0001209191-17-000705 · doc4.xml · derivative · entry 2 JONES HUGH W · CIK 0001182420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,517 Underlying: Common Stock · 4,517 shares Expires 2026-12-30 Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 19:25 UTC |
JONES HUGH WDirector
|
GrantDeferred Share Units · Derivative | 1,898 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-000705 · doc4.xml · derivative · entry 1 JONES HUGH W · CIK 0001182420 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,793 Underlying: Common Stock · 1,898 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 16:50 UTC |
SMALL MICHAELDirector · President and CEO
|
PurchaseCommon Stock | 50,000 | $8.94 | $446,850.00 |
DisclosureSEC source: 0001209191-16-150026 · doc4.xml · nonDerivative · entry 1 SMALL MICHAEL · CIK 0001230004 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 294,832 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.65 to $9.18, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 09, 2016 Filed Nov 10, 2016 10:33 UTC |
MUNDHEIM ROBERT HDirector
|
PurchaseCommon Stock | 5,000 | $9.06 | $45,283.00 |
DisclosureSEC source: 0001209191-16-149237 · doc4.xml · nonDerivative · entry 2 MUNDHEIM ROBERT H · CIK 0001039520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,244 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.05 to $9.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 10:33 UTC |
MUNDHEIM ROBERT HDirector
|
PurchaseCommon Stock | 5,000 | $9.59 | $47,926.00 |
DisclosureSEC source: 0001209191-16-149237 · doc4.xml · nonDerivative · entry 3 MUNDHEIM ROBERT H · CIK 0001039520 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Wife Disclosed balance after: 6,500 F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.57 to $9.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 08, 2016 Filed Nov 10, 2016 10:33 UTC |
MUNDHEIM ROBERT HDirector
|
PurchaseCommon Stock | 5,000 | $9.63 | $48,126.00 |
DisclosureSEC source: 0001209191-16-149237 · doc4.xml · nonDerivative · entry 1 MUNDHEIM ROBERT H · CIK 0001039520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,244 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.55 to $9.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Reflects receipt of shares in connection with a pro rata distribution from Blumenstein/Thorne Aircell Partners, LP, of which the reporting person was a limited partner, exempt under Rule 16a-9. Read SEC document |
| November 07, 2016 Filed Nov 9, 2016 16:10 UTC |
TOWNSEND CHARLES CDirector
|
PurchaseCommon Stock | 300,000 | $9.69 | $2,908,350.00 |
DisclosureSEC source: 0001209191-16-148982 · doc4.xml · nonDerivative · entry 1 TOWNSEND CHARLES C · CIK 0001579494 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 654,267 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.60 to $9.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.direct: Reflects shares held by the Charles C. Townsend III Trust. Mr Townsend, as a co-trustee of the foregoing trust, may be deemed to have beneficial ownership of the shares held by the trust. Mr. Townsend disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 or for any other purpose. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 11:24 UTC |
MUNDHEIM ROBERT HDirector
|
GrantOptions (Right to Buy) · Derivative | 3,892 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001209191-16-143820 · doc4.xml · derivative · entry 2 MUNDHEIM ROBERT H · CIK 0001039520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,892 Underlying: Common Stock · 3,892 shares Expires 2026-09-30 Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 11:24 UTC |
MUNDHEIM ROBERT HDirector
|
GrantDeferred Share Units · Derivative | 3,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-143820 · doc4.xml · derivative · entry 1 MUNDHEIM ROBERT H · CIK 0001039520 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,724 Underlying: Common Stock · 3,057 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 11:22 UTC |
LEMAY RONALD TDirector
|
GrantOptions (Right to Buy) · Derivative | 5,282 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001209191-16-143818 · doc4.xml · derivative · entry 2 LEMAY RONALD T · CIK 0001104293 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,282 Underlying: Common Stock · 5,282 shares Expires 2026-09-30 Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 11:22 UTC |
LEMAY RONALD TDirector
|
GrantDeferred Share Units · Derivative | 2,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-143818 · doc4.xml · derivative · entry 1 LEMAY RONALD T · CIK 0001104293 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,508 Underlying: Common Stock · 2,151 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 15:25 UTC |
THORNE OAKLEIGHDirector · 10% owner
|
GrantOptions (Right to Buy) · Derivative | 3,892 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001209191-16-143822 · doc4.xml · derivative · entry 2 THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,892 Underlying: Common Stock · 3,892 shares Expires 2026-09-30 Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 15:25 UTC |
THORNE OAKLEIGHDirector · 10% owner
|
GrantDeferred Share Units · Derivative | 2,943 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-143822 · doc4.xml · derivative · entry 1 THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,089 Underlying: Common Stock · 2,943 shares Expires not disclosed F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 15:24 UTC |
Payne Christopher DDirector
|
GrantOptions (Right to Buy) · Derivative | 3,892 | $0.00 Strike: $11.04 | $0.00 |
DisclosureSEC source: 0001209191-16-143821 · doc4.xml · derivative · entry 2 Payne Christopher D · CIK 0001612163 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,892 Underlying: Common Stock · 3,892 shares Expires 2026-09-30 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.